Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuja Jhingran

Showing results (81-90 of 222) with videos related to

Pageof 23
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2020
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiationShannon D Armbruster, Bryan M Fellman, Anuja Jhingran, et al.
American Journal of Obstetrics and Gynecology|December 14, 2022
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) studyMichael Frumovitz, Gary B Chisholm, Anuja Jhingran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 16, 2023
Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic reviewDavid Viveros-Carreño, Santiago Vieira-Serna, Carlos Fernando Grillo-Ardila, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 26, 2019
Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancerChristina Steen Vorbeck, Anuja Jhingran, Revathy B Iyer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcomeAnn H Klopp, Anuja Jhingran, Latha Ramdas, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapyLarissa J Lee, Indra J Das, Susan A Higgins, et al.
Physics in Medicine and Biology|October 21, 2005
Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo studyMichael J Price, John L Horton, Kent A Gifford, et al.
Gynecologic Oncology|December 2, 2023
Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvementJulie Sammouri, Aradhana M Venkatesan, Lilie L Lin, et al.
Gynecologic Oncology|September 1, 2023
Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR studyReem H Saab, Gloria Salvo, Naomi R Gonzales, et al.
BMC Cancer|June 9, 2026
Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centreBolanle Adegboyega, Onyinye Balogun, Joy Ogunmuyiwa, et al.
Pageof 23

Showing results (81-90 of 222) with videos related to

Sort By:
Pageof 23
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2020
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiationShannon D Armbruster, Bryan M Fellman, Anuja Jhingran, et al.
American Journal of Obstetrics and Gynecology|December 14, 2022
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) studyMichael Frumovitz, Gary B Chisholm, Anuja Jhingran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 16, 2023
Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic reviewDavid Viveros-Carreño, Santiago Vieira-Serna, Carlos Fernando Grillo-Ardila, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 26, 2019
Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancerChristina Steen Vorbeck, Anuja Jhingran, Revathy B Iyer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcomeAnn H Klopp, Anuja Jhingran, Latha Ramdas, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapyLarissa J Lee, Indra J Das, Susan A Higgins, et al.
Physics in Medicine and Biology|October 21, 2005
Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo studyMichael J Price, John L Horton, Kent A Gifford, et al.
Gynecologic Oncology|December 2, 2023
Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvementJulie Sammouri, Aradhana M Venkatesan, Lilie L Lin, et al.
Gynecologic Oncology|September 1, 2023
Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR studyReem H Saab, Gloria Salvo, Naomi R Gonzales, et al.
BMC Cancer|June 9, 2026
Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centreBolanle Adegboyega, Onyinye Balogun, Joy Ogunmuyiwa, et al.
Pageof 23